trending Market Intelligence /marketintelligence/en/news-insights/trending/g23aJytC3J0z3OeH0cfaKw2 content esgSubNav
In This List

Mutual of Omaha to cover Mass. residents taking HIV prevention drug

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Mutual of Omaha to cover Mass. residents taking HIV prevention drug

Mutual of Omaha Insurance Co. agreed to cover Massachusetts residents using the HIV prevention drug Truvada for pre-exposure prophylaxis.

The company changed its underwriting practices after an investigation by the Massachusetts Attorney General's office and a separate lawsuit filed by the group GLBTQ Legal Advocates & Defenders. The modification means that Truvada will no longer be a disqualifier for any type of accident, life, sickness or health insurance, including long-term care insurance.

Truvada is a tablet containing two types of antiretroviral medication that block HIV from replicating in the body. The drug is a product of Gilead Sciences Inc.